Asfotase Alfa (ALXN1215) ( DrugBank: Asfotase alfa )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
172低ホスファターゼ症2

172. 低ホスファターゼ症


臨床試験数 : 34 薬物数 : 17 - (DrugBank : 4) / 標的遺伝子数 : 3 - 標的パスウェイ数 : 6
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1JPRN-UMIN000014816
2014/08/1111/08/2014A Multicenter study of the safety and efficacy of Asfotase Alfa (ALXN1215) (Human Recombinant Tissue Nonspecific Alkaline Phosphatase Fusion Protein) in patients with hypophosphatasia (HPP)A Multicenter study of the safety and efficacy of Asfotase Alfa (ALXN1215) (Human Recombinant Tissue Nonspecific Alkaline Phosphatase Fusion Protein) in patients with hypophosphatasia (HPP) - Safety and efficacy of Asfotase Alfa in patients with hypophosphatasia (HPP) hypophosphatasiaDrug: Asfotase Alfa (ALXN1215)
Dose: 6mg/kg/week (divided 3 times a week)
HPP study groupTranslational Research Informatics CenterComplete: follow-up completeNot applicableNot applicableMale and Female20Not selectedJapan
2NCT02456038
(ClinicalTrials.gov)
August 201426/3/2015Safety and Efficacy of Asfotase Alfa in Patients With Hypophosphatasia (HPP)A Multicenter Study of the Safety and Efficacy of Asfotase Alfa (ALXN1215) (Human Recombinant Tissue Nonspecific Alkaline Phosphatase Fusion Protein) in Patients With Hypophosphatasia (HPP)HypophosphatasiaDrug: Asfotase Alfa (ALXN1215)Translational Research Informatics Center, Kobe, Hyogo, JapanOsaka University Graduate School of MedicineCompletedN/AN/ABoth13Phase 2Japan